Raptor Pharma Reports Data in Journal of Pediatrics Showed Procysbi Improved Life Quality

By: via Benzinga
Raptor Pharmaceutical Corp. (Nasdaq: RPTP) today announced that data from its open label extension study of delayed-release cysteamine ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.